Inhibrx BiosciencesINBX
那斯達克 · USD
104.94
+1.31
(+1.26%)
收盤 08/25 03:59 (UTC+8)
盤後
104.75
104.75
(-0.18%)
08/25 03:59 (UTC+8)
Inhibrx BiosciencesINBX
104.94
+1.31
(+1.26%)
財務數據
損益表
- -
- 0.00
- -
- 0.00
- -
- 0.01
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | - | - | - | - | 1,300 | - | 100 | - | 100 | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | 1,300 | - | 100 | - | 100 | - |
營業費用 | 32,149 | 30,927 | 30,923 | 33,812 | 28,689 | 42,901 | 50,028 | 46,797 | 160,998 | 73,825 |
研發費用 | 23,899 | 25,217 | 25,349 | 28,535 | 22,267 | 36,877 | 33,367 | 38,893 | 67,632 | 63,851 |
推銷及管理費用 | 8,250 | 5,710 | 5,574 | 5,277 | 6,422 | 6,024 | 16,661 | 7,904 | 93,366 | 9,974 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -32,149 | -30,927 | -30,923 | -33,812 | -27,389 | -42,901 | -49,928 | -46,797 | -160,898 | -73,825 |
其他收入及費用 | 1,195 | 995 | 1,274 | 1,737 | 1,878 | 2,279 | 2,063 | 2,933 | - | 3,245 |
利息費用 | 5,693 | 3,509 | 3,185 | 3,181 | 3,141 | 2,689 | - | - | 5,361 | 8,130 |
稅前純益 | -36,647 | -33,441 | -32,834 | -35,256 | -28,652 | -43,311 | -47,865 | -43,864 | 1,858,013 | -78,710 |
所得稅 | 3 | - | - | - | 2 | - | - | - | 2 | - |
稅後純益 | -36,650 | -33,441 | -32,834 | -35,256 | -28,654 | -43,311 | -47,865 | -43,864 | 1,858,011 | -78,710 |
基本每股稅後盈餘(元) | -2.34 | -2.15 | -2.11 | -2.28 | -1.85 | -2.80 | -3.09 | -2.84 | 127.10 | -5.53 |
稀釋每股稅後盈餘(元) | -2.34 | -2.15 | -2.11 | -2.28 | -1.85 | -2.80 | -4.47 | -5.66 | 125.48 | -1.44 |
基本平均股數(千股) | 15669.00 | 15585.00 | 15533.00 | 15478.00 | 15468.00 | 15468.00 | 15468.00 | 15468.00 | 14619.00 | 14241.00 |
稀釋平均股數(千股) | 15669.00 | 15585.00 | 15533.00 | 15478.00 | 15468.00 | 15468.00 | 15468.00 | 15468.00 | 14807.00 | 14241.00 |
還原基本每股稅後盈餘(元) | -2.34 | -2.15 | -2.11 | -2.28 | -1.85 | -2.80 | -3.09 | -2.84 | 127.10 | -5.53 |
還原稀釋每股稅後盈餘(元) | -2.34 | -2.15 | -2.11 | -2.28 | -1.85 | -2.80 | -4.47 | -5.66 | 125.48 | -1.44 |
還原基本平均股數(千股) | 15,669 | 15,585 | 15,533 | 15,478 | 15,468 | 15,468 | 15,468 | 15,468 | 14,619 | 14,241 |
還原稀釋平均股數(千股) | 15,669 | 15,585 | 15,533 | 15,478 | 15,468 | 15,468 | 15,468 | 15,468 | 14,807 | 14,241 |
EBITDA(千元) | -29,140 | -28,663 | -28,443 | -30,854 | -24,224 | -39,414 | -47,176 | -43,104 | 1,863,850 | -68,978 |